Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Translated title of the contribution: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

C. Bossard, K. Belhadj, F. Reyes, N. Martin-Garcia, F. Berger, J.A. Kummer, J. Brière, A-C. Baglin, S. Cheze, J. Bosq, V. Ribrag, C. Gisselbrecht, N. Mounier, P. Gaulard

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionExpression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Original languageUndefined/Unknown
Pages (from-to)2183-2189
Number of pages7
JournalBlood
Volume109
Issue number5
Publication statusPublished - 2007

Cite this